FDA Drug Shortage Database
Metronidazole (Flagyl) shortage
The FDA Drug Shortage Database lists 3 of 4 metronidazole presentations as limited or unavailable (updated October 6, 2026); the first entry was posted on January 13, 2022. 1 more presentation is on the list as available.
- Generic listed
- In shortage
- Boxed warning
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 500mg/100ml injection | 3 | 1 | 0 |
Which presentations are listed?
Limited or unavailable now (3)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Metronidazole In Plastic Container, Injection, 500 mg/100 mL (NDC 47335-993-01) | Gland Pharma Limited | Current posted January 13, 2022, updated July 22, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Metronidazole in Flexible Container, Injection, 500 mg/100 mL (NDC 0409-0152-24) | InfoRLife SA | Current posted January 13, 2022, updated October 6, 2026 | Limited Availability; Other |
| Metronidazole, Injection, 500 mg/100 mL (NDC 25021-131-82) | InfoRLife SA | Current posted January 13, 2022, updated August 18, 2026 | Limited Availability; Other |
Listed now, available (1)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48) | Baxter Healthcare | Current posted January 13, 2022, updated October 2, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
Are medicines for the same conditions short too?
Medicines whose labels share an indication with this one, and their own shortage status; listed as records, not substitutes.
| Medicine | Shared indication | Shortage | Generic labelers | Pharmacy cost |
|---|---|---|---|---|
| Amoxicillin | Bacterial infections | No current entry | 38 labelers | $0.0788 per capsule 500 mg capsule |
| Azithromycin | Bacterial infections | A presentation being discontinued | 55 labelers | $0.266 per tablet 250 mg tablet |
| Cephalexin | Bacterial infections | No current entry | 35 labelers | $0.120 per capsule 500 mg capsule |
| Clindamycin | Bacterial infections | In shortage | 60 labelers | $0.137 per gram 1% gel |
| Sulfamethoxazole and trimethoprim | Bacterial infections | No current entry | 44 labelers | $0.0448 per tablet Sulfamethoxazole-tmp ds tablet |
| Levofloxacin | Bacterial infections | No current entry | 44 labelers | $0.259 per tablet 750 mg tablet |
| Cefdinir | Bacterial infections | No current entry | 26 labelers | $0.458 per capsule 300 mg capsule |
| Erythromycin | Bacterial infections | No current entry | 38 labelers | $1.96 per tablet 250 mg tablet |
| Clarithromycin | Bacterial infections | No current entry | 26 labelers | $0.466 per tablet 500 mg tablet |
| Cefuroxime | Bacterial infections | No current entry | 19 labelers | $0.280 per tablet 250 mg tablet |
| Cefadroxil | Bacterial infections | No current entry | 19 labelers | $0.269 per capsule 500 mg capsule |
| Cefpodoxime | Bacterial infections | No current entry | 11 labelers | $1.04 per tablet 100 mg tablet |
Source: FDA drug labels, FDA Drug Shortage Database, NDC Directory, CMS NADAC of October 7, 2026 (FDA files October 8, 2026)
What next?
- Every shortage now
- medicines by presentations in shortage